Connection

Alicia Jenkins to Insulin

This is a "connection" page, showing publications Alicia Jenkins has written about Insulin.
Connection Strength

4.924
  1. Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes. Sci Rep. 2021 08 17; 11(1):16656.
    View in: PubMed
    Score: 0.603
  2. Estimated insulin sensitivity in Type 1 diabetes adults using clinical and research biomarkers. Diabetes Res Clin Pract. 2020 Sep; 167:108359.
    View in: PubMed
    Score: 0.561
  3. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment. BMJ Open. 2019 12 29; 9(12):e033059.
    View in: PubMed
    Score: 0.539
  4. Insulin Pumps: Review of Technological Advancement in Diabetes Management. Am J Med Sci. 2019 11; 358(5):326-331.
    View in: PubMed
    Score: 0.526
  5. Suboptimal behaviour and knowledge regarding overnight glycaemia in adults with type 1 diabetes is common. Intern Med J. 2018 09; 48(9):1080-1086.
    View in: PubMed
    Score: 0.491
  6. An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life. Diabetes Technol Ther. 2011 Feb; 13(2):105-9.
    View in: PubMed
    Score: 0.290
  7. Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial. Diabetes Care. 2010 Jun; 33(6):1242-8.
    View in: PubMed
    Score: 0.273
  8. Independent euglycaemic hyperinsulinaemic clamp studies validate clinically applicable formulae to estimate insulin sensitivity in people with type 1 diabetes. Diabetes Metab Syndr. 2023 Jan; 17(1):102691.
    View in: PubMed
    Score: 0.165
  9. Insulin antibodies are prevalent in adults with type 1 diabetes referred for islet cell transplantation and are modified by islet transplantation and immunosuppression: an Australian experience. Intern Med J. 2022 08; 52(8):1434-1436.
    View in: PubMed
    Score: 0.161
  10. Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial. Diabetes Care. 2020 12; 43(12):3024-3033.
    View in: PubMed
    Score: 0.142
  11. Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study. Diabetes Care. 2020 02; 43(2):480-483.
    View in: PubMed
    Score: 0.134
  12. Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study. Diabetes Technol Ther. 2019 01; 21(1):56-58.
    View in: PubMed
    Score: 0.126
  13. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol. BMJ Open. 2018 06 09; 8(6):e020274.
    View in: PubMed
    Score: 0.121
  14. Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose Suspend. Diabetes Technol Ther. 2017 07; 19(7):438-439.
    View in: PubMed
    Score: 0.112
  15. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study. Diabetes Technol Ther. 2016 12; 18(12):772-783.
    View in: PubMed
    Score: 0.108
  16. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study. Crit Care Med. 2016 09; 44(9):1695-703.
    View in: PubMed
    Score: 0.107
  17. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation. 2005 May 17; 111(19):2446-53.
    View in: PubMed
    Score: 0.049
  18. An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes. Diabetes Technol Ther. 2023 02; 25(2):108-115.
    View in: PubMed
    Score: 0.041
  19. Late Afternoon Vigorous Exercise Increases Postmeal but Not Overnight Hypoglycemia in Adults with Type 1 Diabetes Managed with Automated Insulin Delivery. Diabetes Technol Ther. 2022 Dec; 24(12):873-880.
    View in: PubMed
    Score: 0.041
  20. Upload and Review of Insulin Pump and Glucose Sensor Data by Adults with Type 1 Diabetes: A Clinic Audit. Diabetes Technol Ther. 2022 07; 24(7):531-534.
    View in: PubMed
    Score: 0.040
  21. A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes. Diabetes Care. 2022 01 01; 45(1):194-203.
    View in: PubMed
    Score: 0.039
  22. Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provision. Diabetes Res Clin Pract. 2021 Sep; 179:109000.
    View in: PubMed
    Score: 0.038
  23. Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections. Diabetes Technol Ther. 2021 06; 23(6):460-466.
    View in: PubMed
    Score: 0.036
  24. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study. Diabetes Technol Ther. 2019 09; 21(9):499-506.
    View in: PubMed
    Score: 0.033
  25. Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial. Diabetes Obes Metab. 2017 04; 19(4):509-516.
    View in: PubMed
    Score: 0.028
  26. HDL as a Target for Glycemic Control. Curr Drug Targets. 2017; 18(6):651-673.
    View in: PubMed
    Score: 0.027
  27. Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes. J Lipid Res. 2016 Feb; 57(2):310-7.
    View in: PubMed
    Score: 0.025
  28. HDL-C and HDL-C/ApoA-I predict long-term progression of glycemia in established type 2 diabetes. Diabetes Care. 2014 Aug; 37(8):2351-8.
    View in: PubMed
    Score: 0.023
  29. Normalized NEFA dynamics during an OGTT after islet transplantation. Transplantation. 2012 Oct 15; 94(7):e49-51.
    View in: PubMed
    Score: 0.020
  30. Cardiovascular risk factors in pre-pubertal Malays: effects of diabetic parentage. Diabetes Res Clin Pract. 2007 Apr; 76(1):119-25.
    View in: PubMed
    Score: 0.013
  31. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 2003 Feb; 52(2):453-62.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.